RetinalGenix Technologies Inc. to Acquire Private Company
Ticker: RTGN · Form: 8-K · Filed: Apr 8, 2024 · CIK: 1836295
| Field | Detail |
|---|---|
| Company | Retinalgenix Technologies Inc. (RTGN) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, letter-of-intent
Related Tickers: RGIX
TL;DR
RGIX is buying a private company, deal expected Q2 2024.
AI Summary
RetinalGenix Technologies Inc. announced on April 2, 2024, that it has entered into a binding letter of intent to acquire all of the outstanding equity interests of a privately held company. The acquisition is expected to close in the second quarter of 2024, subject to customary closing conditions. The company did not disclose the name of the target company or the purchase price.
Why It Matters
This acquisition could significantly expand RetinalGenix's business operations and market reach, potentially leading to increased revenue and shareholder value.
Risk Assessment
Risk Level: medium — The acquisition is subject to closing conditions and the target company's identity and financial terms are not yet disclosed, introducing uncertainty.
Key Players & Entities
- RetinalGenix Technologies Inc. (company) — Registrant
- April 2, 2024 (date) — Date of earliest event reported
- second quarter of 2024 (date) — Expected closing period for acquisition
FAQ
What is the name of the privately held company RetinalGenix Technologies Inc. intends to acquire?
The filing does not disclose the name of the privately held company.
What is the purchase price for the acquisition?
The filing does not disclose the purchase price for the acquisition.
When is the acquisition expected to close?
The acquisition is expected to close in the second quarter of 2024.
What are the conditions for the closing of the acquisition?
The acquisition is subject to customary closing conditions.
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report on the "Other Events" related to the binding letter of intent for an acquisition.
Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2024-04-08 16:05:24
Filing Documents
- form8-k.htm (8-K) — 31KB
- 0001493152-24-013775.txt ( ) — 195KB
- rtgn-20240402.xsd (EX-101.SCH) — 3KB
- rtgn-20240402_lab.xml (EX-101.LAB) — 33KB
- rtgn-20240402_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RETINALGENIX TECHNOLOGIES INC. Date: April 8, 2024 By: /s/ Jerry Katzman Jerry Katzman Chief Executive Officer -3-